Di-Adreson-F® aquosum

Di-Adreson-F aquosum (prednisolone) is a medical need product specifically designed for the intrathecal treatment of Acute Lymphatic Leukemia (ALL) in children and adolescents.

Di-Adreson-F aquosum (DAF) is prescribed to suppress inflammatory responses of various origins and as an immunosuppressive agent.

DAF does not contain preservatives, complex formers (EDTA) or buffers and can therefore be used safely, also for administration in the head and neck area or intrathecal administration. DAF is administered by injection.